Results 1 to 10 of about 457,403 (331)
Role of Toll-Like Receptor 5 in the Development of Ulcerative Colitis [PDF]
Archives of Razi Institute, 2021 Inflammatory bowel disease (ulcerative colitis and Crohn’s disease) is a remitting and relapsing disease that affects millions of people worldwide. In the intestine, homeostasis between repair and signaling of the proinflammatory of the immune system is ...
A Falah Alshimerry +2 more
doaj +1 more source
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
New England Journal of Medicine, 2021 BACKGROUND Ozanimod, a selective sphingosine-1-phosphate receptor modulator, is under investigation for the treatment of inflammatory bowel disease. METHODS We conducted a phase 3, multicenter, randomized, double-blind, placebo-controlled trial of ...
W. Sandborn +15 more
semanticscholar +1 more source
The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe
BMC Gastroenterology, 2021 Background Ulcerative colitis (UC) is an inflammatory bowel disease with increasing prevalence worldwide. Current treatment strategies place considerable economic and humanistic burdens on patients.
Leonardo Ruiz-Casas +14 more
doaj +1 more source
Modern principles of conservative treatment of mild and moderate forms of ulcerative colitis
Лечащий Врач, 2022 Ulcerative colitis is a chronic disease characterized by inflammation that usually begins in the rectum and diffusely spreads proximally, involving part or all of the colonic mucosa.
O. V. Golovenko
doaj +1 more source
Ozanimod: A Review in Ulcerative Colitis
Drugs, 2022 Ozanimod (Zeposia®) is the first sphingosine-1-phosphate receptor (S1PR) modulator to be approved for the treatment of adults with moderately to severely active ulcerative colitis in the USA, and in adults with moderately to severely active ulcerative ...
J. Paik
semanticscholar +1 more source
Scientific Reports, 2021 Ulcerative colitis is a chronic, idiopathic, and inflammatory disease of the rectal and colonic mucosa, the behavior of which is of heterogeneity in individuals.
Lijie Lai +4 more
doaj +1 more source
Medicina, 2023 Background and Objectives: Atherosclerosis is one of inflammatory bowel disease’s most significant cardiovascular manifestations. This research aimed to examine the relationship between biochemical, haemostatic, and immune parameters of atherosclerosis ...
Sofija I. Lugonja +9 more
doaj +1 more source
Oral manifestation of ulcerative colitis [PDF]
Stomatološki glasnik Srbije, 2022 Introduction Ulcerative colitis is an inflammatory bowel disease. Primary involvement is the colon. Changes in the oral cavity may occur as the part of extraintestinal manifestations of the disease.
Đuričković Aleksa +1 more
doaj +1 more source
Ulcerative colitis: an update.
Clinical medicine (London), 2021 Ulcerative colitis is a relapsing and remitting disease that is increasing in incidence and prevalence. Management aims to achieve rapid resolution of symptoms, mucosal healing and improvement in a patient's quality of life.
J. Segal, J. LeBlanc, A. Hart
semanticscholar +1 more source
Serum antibodies in first-degree relatives of patients with IBD: A marker of disease susceptibility? A follow-up pilot-study after 7 years [PDF]
, 2005 Introduction: Various disease-specific serum antibodies were described in patients with inflammatory bowel disease and their yet healthy first-degree relatives.
Bansi DS +29 more
core +5 more sources